Debra Fleming, in Jefferson, LA - Case Manager/Care Coordinator

Debra Fleming, is a Case Manager/care Coordinator based in Jefferson, Louisiana. Debra Fleming is licensed to practice in Louisiana (license number 7672) and her current practice location is 601 Lauricella Ave, Jefferson, Louisiana. She can be reached at her office (for appointments etc.) via phone at (504) 450-9500.

NPI number for Debra Fleming is 1316474166 and her current mailing address is 601 Lauricella Ave, Jefferson, Louisiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1316474166.

Contact Information

	Debra Fleming,
	601 Lauricella Ave, Jefferson, LA 70121-1711
	(504) 450-9500
	Not Available

Healthcare Provider's Profile

Full Name	Debra Fleming
Gender	Female
Speciality	Case Manager/care Coordinator
Location	601 Lauricella Ave, Jefferson, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1316474166
Provider Enumeration Date: 05/11/2017
Last Update Date: 01/02/2019

Medical Identifiers

Medical identifiers for Debra Fleming such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316474166	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	(* (Not Available))	Secondary
171M00000X	Case Manager/care Coordinator	7672 (Louisiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Debra Fleming is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Debra Fleming, 601 Lauricella Ave, Jefferson, LA 70121-1711 Ph: () -	Debra Fleming, 601 Lauricella Ave, Jefferson, LA 70121-1711 Ph: (504) 450-9500

News Archive

Report: Top insurance execs pulled in nearly $200 million in compensation last year

The Los Angeles Times: "The top executives at the nation's five largest for-profit health insurance companies pulled in nearly $200 million in compensation last year — while their businesses prepared to hit ratepayers with double-digit premium increases, according to a new analysis conducted by healthcare activists. The leaders of Cigna Corp., Humana Inc., UnitedHealth Group and WellPoint Inc. each in effect received raises in 2009, the report concluded, based on an analysis of company reports filed with the Security and Exchange Commission.

BGU researchers discover gene that causes nighttime atrial fibrillation

Genetic studies spanning three generations of a Persian Jewish family by researchers at Ben-Gurion University of the Negev. have identified a gene that causes nighttime atrial fibrillation (AFib).

Simple bedside test improves diagnosis of chronic back pain, could guide treatment

A simple and inexpensive method of assessing pain, developed by Massachusetts General Hospital (MGH) researchers, is better than currently used techniques for distinguishing neuropathic pain - pain caused by damage to the nervous system - from other types of chronic back pain.

Viewpoints: Calif. could take a lesson from Wis. reforms; Republican advocates a 'Nixon to China' embrace of Medicare for all

The state's teachers union, Wisconsinites learned, had used its power to collectively bargain for healthcare benefits to demand that local school districts provide coverage through a nonprofit insurer affiliated with the union. Once the state ended bargaining on healthcare, school boards began competitively bidding out their health insurance. By the opening of the new school year in September, just two months after the budget bill went into effect, 23 districts had rebid their contracts, saving $16 million, or an average of $211 per student.

BRCA mutations carry risks for salivary gland cancer, breast cancer

The risk of developing cancer in a salivary gland might be higher in people with mutations in either of two genes associated with breast and ovarian cancer, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

Debra Fleming, - Counselor in Jefferson, LA